Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN) and Celcuity (NASDAQ:CELC).
Autolus Therapeutics has a consensus price target of $9.14.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $1.95 last updated February 20, 2025 at 7:26 PM EST.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.